Vagus Nerve Stimulator Market

Vagus Nerve Stimulator Market (Product Type: Implantable and Non-invasive; and Application: Pain Management, Epileptic Seizures, Depression and Anxiety, Obesity Management, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Global Vagus Nerve Stimulator Market Outlook 2031

  • The global industry was valued at US$ 444.7 Mn in 2021
  • It is projected to advance at a CAGR of 10.1% between 2022 and 2031 and reach more than US$ 1.1 Bn by the end of 2031

Analysts’ Viewpoint on Market Scenario

Increase in the prevalence of epilepsy and anxiety disorders is driving the global vagus nerve stimulator market size. Vagus Nerve Stimulation (VNS) devices send mild electrical impulses to the vagus nerve for the treatment of epilepsy and depression. Vagus nerve stimulators are also used for the treatment of anxiety disorders, migraines, and cluster headaches.

R&D of advanced and effective vagus nerve stimulators is expected to augment market expansion during the forecast period. Noninvasive vagus nerve stimulation devices do not require surgical implantation. Thus, vagus nerve stimulator manufacturers are launching advanced non-invasive VNS devices to broaden their revenue share.

Vagus Nerve Stimulator Market

Vagus Nerve Stimulator Market Introduction

Vagus nerve stimulator is a medical device that is used to stimulate the vagus nerve ‒ a cranial nerve that runs from the brainstem to the abdomen. VNS can effectively reduce the frequency of seizures in patients with epilepsy. It can also mitigate symptoms of depression and anxiety in some patients.

However, VNS is not a cure-all and may not be effective for everyone. It is important to discuss the potential risks and benefits of VNS with a healthcare provider before considering this treatment option.

Rise in Prevalence of Epilepsy Propelling Global Vagus Nerve Stimulator Market Progress

VNS is widely employed for the treatment of epilepsy. Genetic factors, head injuries, strokes, brain tumors, and infectious diseases are various factors that can contribute to the development of epilepsy.

According to a study conducted by the International League Against Epilepsy (ILAE), VNS is effective in reducing seizures in a subset of patients with epilepsy.

Additionally, it may be a useful adjunctive treatment for patients who have not responded to other therapies. Increase in the geriatric population is anticipated to fuel market development in the next few years. People above 65 years of age are at high risk of epilepsy, head injuries, and strokes.

R&D of Advanced and Effective Vagus Nerve Stimulators

Technological advancements have led to the development of more effective vagus nerve stimulators. These devices can be tailored to specific patient needs and deliver precise, targeted stimulation to the vagus nerve. Vendors in the industry are launching compact and portable products to expand their vagus nerve stimulator market share.

Vagus nerve stimulators developed with advanced technologies facilitate a more personalized treatment approach. They can also be more effective in reducing the frequency and severity of certain conditions. Manufacturers are incorporating IoT features, such as Bluetooth connectivity and smartphone app integration, to enable remote monitoring services and adjustment of stimulation settings. Therefore, the availability of IoT-enabled products is likely to propel market statistics in the near future.

Increase in Demand for Implantable Vagus Nerve Stimulators

According to the latest market trends, the implantable product type segment held the largest share of the industry in 2021. Implantable vagus nerve stimulators are generally considered safe and effective with surgical procedures.

Additionally, the development of more advanced and effective implantable vagus nerve stimulators and the incorporation of IoT features have contributed to growth of the segment. Implementation of favorable reimbursement policies for implantable vagus nerve stimulators is also driving the segment.

Growth in Awareness Regarding Epilepsy

The epileptic seizures application segment held largest share of the vagus nerve stimulator market in 2021. Rise in awareness about epilepsy and related treatments is boosting the segment. Moreover, adoption of new guidelines and the availability of funding for the treatment of epileptic seizures is also driving the segment.

Surge in Preference for Robust Hospitals to Treat Chronic Epilepsy

The hospitals end-user segment dominated the industry in 2021. This can be ascribed to the availability of a robust hospital infrastructure and surge in preference for hospitals for chronic epilepsy treatment. Rise in healthcare expenditure and increase in access to implantable vagus nerve stimulators are also augmenting the segment.

Regional Outlook of Global Vagus Nerve Stimulator Market

North America is expected to account for major share of the industry during the forecast period. Surge in government funding and increase in awareness about epilepsy and depression are driving market revenue in the region.

The market in Asia Pacific is projected to grow at a rapid pace during 2022-2031. High prevalence of depression, anxiety, epilepsy, and obesity is contributing to the vagus nerve stimulator industry growth in the region. Several governments in Asia Pacific are investing significantly in healthcare infrastructure development.

Organizations such as The Asia-Pacific Centre for Neuromodulation (APCN) are at the forefront of boosting adoption of Deep Brain Stimulation devices (DBS) for the treatment of neurological diseases in the region.

Analysis of Key Players

The industry is highly consolidated, with the presence of a small number of dominant vendors. Most companies adopt strategic alliances to broaden their revenue and market share. The vagus nerve stimulator market report profiles leading players based on parameters such as company overview, financial overview, strategies, portfolio, segments, and recent developments.

ReShape Lifesciences, Inc., LivaNova LLC, electroCore, Inc., MicroTransponder Inc., Parasym Ltd., Cerebral Inc., Cerbomed GmbH, Neuvana, LLC, Nevro Corp., and NeuroPace Inc. are key entities operating in the industry.

Key Developments in Global Vagus Nerve Stimulator Market

  • In November 2022, electroCore, Inc., a bio-electronic medicine firm, announced that gammaCore Sapphire - the first and only FDA-granted non-invasive vagus nerve stimulator indicated for the treatment of headaches – was issued a National Code Number in Belgium
  • In May 2022, Health Canada, a department of the Government of Canada, approved the use of the Dolphin vagal nerve stimulator for the treatment of symptoms such as headaches, cough, shortness of breath, joint and muscle pain, fatigue, and brain fog in COVID-19 patients
  • In March 2020, LivaNova received the CE Mark approval for ‘Symmetry’, an innovative VNS therapy system for the treatment of depression

Global Vagus Nerve Stimulator Market Snapshot

Attribute

Detail

Size in 2021

US$ 444.7 Mn

Forecast (Value) in 2031

More than US$ 1.1 Bn

Growth Rate (CAGR) for 2022-2031

10.1%

Forecast Period

2022–2031

Historical Data Available for

2017–2021

Quantitative Units

US$ Mn/Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and key trend analysis.

Competition Landscape

  • Company profiles section includes overview, product portfolio, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Segmentation

  • Product Type
    • Implantable
    • Non-invasive (tVNS)
  • Application
    • Pain Management
    • Epileptic Seizures
    • Obesity Management
    • Depression and Anxiety
    • Others
  • Biomaterial
    • Ceramics
    • Metallic
    • Polymeric
  • End-user
    • Hospitals
    • Ambulatory Surgical Centers (ASCs)
    • Others
  • Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • ReShape Lifesciences, Inc.
  • LivaNova LLC
  • electroCore, Inc.
  • MicroTransponder Inc.
  • Parasym Ltd.
  • Cerebral Inc.
  • Cerbomed GmbH
  • Neuvana, LLC
  • Nevro Corp.
  • NeuroPace Inc.
  • Other Prominent Players

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global vagus nerve stimulator market in 2021?

It was valued at US$ 444.7 Mn in 2021.

How big will be the industry in 2031?

It is projected to reach more than US$ 1.1 Bn by 2031.

What will be the CAGR during the forecast period?

It is anticipated to be 10.1% from 2022 to 2031.

Which are the prominent trends that affect industry growth?

Increase in prevalence of epilepsy and anxiety disorders and R&D of advanced and effective vagus nerve stimulators.

Which region will account for major share?

North America is expected to account for major share during the forecast period.

Who are the prominent players in the market?

ReShape Lifesciences, Inc., LivaNova LLC, electroCore, Inc., MicroTransponder Inc., Parasym Ltd., Cerebral Inc., Cerbomed GmbH, Neuvana, LLC, Nevro Corp., and NeuroPace Inc.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Vagus Nerve Stimulator Market

4. Market Overview

    4.1. Introduction

        4.1.1. Segmentation Definition

        4.1.2. Industry Evolution /Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Vagus Nerve Stimulator Market Analysis and Forecast, 2017–2031

5. Key Insights

    5.1. Technological Advancements

    5.2. Regulatory Scenario by Region/Globally

    5.3. Pricing Analysis

    5.4. COVID-19 Impact Analysis

6. Global Vagus Nerve Stimulator Market Analysis and Forecast, by Product Type

    6.1. Introduction & Definition

    6.2. Key Findings/Developments

    6.3. Market Value Forecast, by Product Type, 2017–2031

        6.3.1. Implantable

        6.3.2. Non-invasive (tVNS)

    6.4. Market Attractiveness Analysis, By Product Type

7. Global Vagus Nerve Stimulator Market Analysis and Forecast, by Biomaterial

    7.1. Introduction & Definition

    7.2. Key Findings/Developments

    7.3. Market Value Forecast, by Biomaterial, 2017–2031

        7.3.1. Ceramics

        7.3.2. Metallic

        7.3.3. Polymeric

    7.4. Market Attractiveness Analysis, By Biomaterial

8. Global Vagus Nerve Stimulator Market Analysis and Forecast, by Application

    8.1. Introduction & Definition

    8.2. Key Findings/Developments

    8.3. Market Value Forecast, by Application, 2017–2031

        8.3.1. Pain Management

        8.3.2. Epileptic Seizures

        8.3.3. Depression and Anxiety

        8.3.4. Obesity Management

        8.3.5. Others

    8.4. Market Attractiveness Analysis, By Application

9. Global Vagus Nerve Stimulator Market Analysis and Forecast, by End-user

    9.1. Introduction & Definition

    9.2. Key Findings/Developments

    9.3. Market Value Forecast, by End-user, 2017–2031

        9.3.1. Hospitals

        9.3.2. Ambulatory Surgical Centers (ASCs)

        9.3.3. Others

    9.4. Market Attractiveness Analysis, By End-user

10. Global Vagus Nerve Stimulator Market Analysis and Forecast, by Region

    10.1. Key Findings

    10.2. Market Value Forecast, by Region

        10.2.1. North America

        10.2.2. Europe

        10.2.3. Asia Pacific

        10.2.4. Latin America

        10.2.5. Middle East & Africa

    10.3. Market Attractiveness Analysis, By Region

11. North America Vagus Nerve Stimulator Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Product Type, 2017–2031

        11.2.1. Implantable

        11.2.2. Non-invasive (tVNS)

    11.3. Market Value Forecast, by Biomaterial, 2017–2031

        11.3.1. Ceramics

        11.3.2. Metallic

        11.3.3. Polymeric

    11.4. Market Value Forecast, by Application, 2017–2031

        11.4.1. Pain Management

        11.4.2. Epileptic Seizures

        11.4.3. Depression and Anxiety

        11.4.4. Obesity Management

        11.4.5. Others

    11.5. Market Value Forecast, by End-user, 2017–2031

        11.5.1. Hospitals

        11.5.2. Ambulatory Surgical Centers (ASCs)

        11.5.3. Others

    11.6. Market Value Forecast, by Country, 2017–2031

        11.6.1. U.S.

        11.6.2. Canada

    11.7. Market Attractiveness Analysis

        11.7.1. By Product Type

        11.7.2. By Biomaterial

        11.7.3. By Application

        11.7.4. By End-user

        11.7.5. By Country

12. Europe Vagus Nerve Stimulator Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Product Type, 2017–2031

        12.2.1. Implantable

        12.2.2. Non-invasive (tVNS)

    12.3. Market Value Forecast, by Biomaterial, 2017–2031

        12.3.1. Ceramics

        12.3.2. Metallic

        12.3.3. Polymeric

    12.4. Market Value Forecast, by Application, 2017–2031

        12.4.1. Pain Management

        12.4.2. Epileptic Seizures

        12.4.3. Depression and Anxiety

        12.4.4. Obesity Management

        12.4.5. Others

    12.5. Market Value Forecast, by End-user, 2017–2031

        12.5.1. Hospitals

        12.5.2. Ambulatory Surgical Centers (ASCs)

        12.5.3. Others

    12.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.6.1. Germany

        12.6.2. U.K.

        12.6.3. France

        12.6.4. Spain

        12.6.5. Italy

        12.6.6. Rest of Europe

    12.7. Market Attractiveness Analysis

        12.7.1. By Product Type

        12.7.2. By Biomaterial

        12.7.3. By Application

        12.7.4. By End-user

        12.7.5. By Country/Sub-region

13. Asia Pacific Vagus Nerve Stimulator Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Product Type, 2017–2031

        13.2.1. Implantable

        13.2.2. Non-invasive (tVNS)

    13.3. Market Value Forecast, by Biomaterial, 2017–2031

        13.3.1. Ceramics

        13.3.2. Metallic

        13.3.3. Polymeric

    13.4. Market Value Forecast, by Application, 2017–2031

        13.4.1. Pain Management

        13.4.2. Epileptic Seizures

        13.4.3. Depression and Anxiety

        13.4.4. Obesity Management

        13.4.5. Others

    13.5. Market Value Forecast, by End-user, 2017–2031

        13.5.1. Hospitals

        13.5.2. Ambulatory Surgical Centers (ASCs)

        13.5.3. Others

    13.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.6.1. China

        13.6.2. Japan

        13.6.3. India

        13.6.4. Australia & New Zealand

        13.6.5. Rest of Asia Pacific

    13.7. Market Attractiveness Analysis

        13.7.1. By Product Type

        13.7.2. By Biomaterial

        13.7.3. By Application

        13.7.4. By End-user

        13.7.5. By Country/Sub-region

14. Latin America Vagus Nerve Stimulator Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Product Type, 2017–2031

        14.2.1. Implantable

        14.2.2. Non-invasive (tVNS)

    14.3. Market Value Forecast, by Biomaterial, 2017–2031

        14.3.1. Ceramics

        14.3.2. Metallic

        14.3.3. Polymeric

    14.4. Market Value Forecast, by Application, 2017–2031

        14.4.1. Pain Management

        14.4.2. Epileptic Seizures

        14.4.3. Depression and Anxiety

        14.4.4. Obesity Management

        14.4.5. Others

    14.5. Market Value Forecast, by End-user, 2017–2031

        14.5.1. Hospitals

        14.5.2. Ambulatory Surgical Centers (ASCs)

        14.5.3. Others

    14.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        14.6.1. Brazil

        14.6.2. Mexico

        14.6.3. Rest of Latin America

    14.7. Market Attractiveness Analysis

        14.7.1. By Product Type

        14.7.2. By Biomaterial

        14.7.3. By Application

        14.7.4. By End-user

        14.7.5. By Country/Sub-region

15. Middle East & Africa Vagus Nerve Stimulator Market Analysis and Forecast

    15.1. Introduction

        15.1.1. Key Findings

    15.2. Market Value Forecast, by Product Type, 2017–2031

        15.2.1. Implantable

        15.2.2. Non-invasive (tVNS)

    15.3. Market Value Forecast, by Biomaterial, 2017–2031

        15.3.1. Ceramics

        15.3.2. Metallic

        15.3.3. Polymeric

    15.4. Market Value Forecast, by Application, 2017–2031

        15.4.1. Pain Management

        15.4.2. Epileptic Seizures

        15.4.3. Depression and Anxiety

        15.4.4. Obesity Management

        15.4.5. Others

    15.5. Market Value Forecast, by End-user, 2017–2031

        15.5.1. Hospitals

        15.5.2. Ambulatory Surgical Centers (ASCs)

        15.5.3. Others

    15.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        15.6.1. GCC Countries

        15.6.2. South Africa

        15.6.3. Rest of Middle East & Africa

    15.7. Market Attractiveness Analysis

        15.7.1. By Product Type

        15.7.2. By Biomaterial

        15.7.3. By Application

        15.7.4. By End-user

        15.7.5. By Country/Sub-region

16. Competition Landscape

    16.1. Market Player – Competition Matrix (By Tier and Size of Companies)

    16.2. Market Share Analysis, by Company, 2021

    16.3. Company Profiles

        16.3.1. ReShape Lifesciences, Inc.

            16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.1.2. Product Portfolio

            16.3.1.3. SWOT Analysis

            16.3.1.4. Strategic Overview

        16.3.2. LivaNova LLC

            16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.2.2. Product Portfolio

            16.3.2.3. SWOT Analysis

            16.3.2.4. Strategic Overview

        16.3.3. electroCore, Inc.

            16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.3.2. Product Portfolio

            16.3.3.3. SWOT Analysis

            16.3.3.4. Strategic Overview

        16.3.4. MicroTransponder Inc.

            16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.4.2. Product Portfolio

            16.3.4.3. SWOT Analysis

            16.3.4.4. Strategic Overview

        16.3.5. Parasym Ltd.

            16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.5.2. Product Portfolio

            16.3.5.3. SWOT Analysis

            16.3.5.4. Strategic Overview

        16.3.6. Cerebral Inc.

            16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.6.2. Product Portfolio

            16.3.6.3. SWOT Analysis

            16.3.6.4. Strategic Overview

        16.3.7. Cerbomed GmbH

            16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.7.2. Product Portfolio

            16.3.7.3. SWOT Analysis

            16.3.7.4. Strategic Overview

        16.3.8. Neuvana, LLC

            16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.8.2. Product Portfolio

            16.3.8.3. SWOT Analysis

            16.3.8.4. Strategic Overview

        16.3.9. Nevro Corp.

            16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.9.2. Product Portfolio

            16.3.9.3. SWOT Analysis

            16.3.9.4. Strategic Overview

        16.3.10. NeuroPace Inc.

            16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.10.2. Product Portfolio

            16.3.10.3. SWOT Analysis

            16.3.10.4. Strategic Overview

List of Tables

Table 01: Global Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 02: Global Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Implantable, 2017–2031

Table 03: Global Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Biomaterial, 2017–2031

Table 04: Global Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 05: Global Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 06: Global Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 07: North America Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 08: North America Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Implantable, 2017–2031

Table 09: North America Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Biomaterial, 2017–2031

Table 10: North America Vagus Nerve Stimulator Market) Forecast, by Biomaterial, 2017–2031

Table 11: North America Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 12: North America Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 13: North America Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 14: Europe Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 15: Europe Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Implantable, 2017–2031

Table 16: Europe Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Biomaterial, 2017–2031

Table 17: Europe Vagus Nerve Stimulator Market Forecast, by Biomaterial, 2017–2031

Table 18: Europe Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 19: Europe Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 20: Europe Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 21: Asia Pacific Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 22: Asia Pacific Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Implantable, 2017–2031

Table 23: Asia Pacific Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Biomaterial, 2017–2031

Table 24: Asia Pacific Vagus Nerve Stimulator Market, by Biomaterial, 2017–2031

Table 25: Asia Pacific Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 26: Asia Pacific Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 27: Asia Pacific Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 28: Latin America Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 29: Latin America Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Implantable, 2017–2031

Table 30: Latin America Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Biomaterial, 2017–2031

Table 31: Latin America Vagus Nerve Stimulator Market Forecast, by Biomaterial, 2017–2031

Table 32: Latin America Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 33: Latin America Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 34: Latin America Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 35: Middle East & Africa Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 36: Middle East & Africa Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Implantable, 2017–2031

Table 37: Middle East & Africa Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Biomaterial, 2017–2031

Table 38: Middle East & Africa Vagus Nerve Stimulator Market Forecast, by Biomaterial, 2017–2031

Table 39: Middle East & Africa Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 40: Middle East & Africa Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 41: Middle East & Africa Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

List of Figures

Figure 01: Global Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Vagus Nerve Stimulator Market Value Share, by Product Type (2021)

Figure 03: Global Vagus Nerve Stimulator Market Value Share, by Biomaterial (2021)

Figure 04: Global Vagus Nerve Stimulator Market Value Share, by Application (2021)

Figure 05: Global Vagus Nerve Stimulator Market Value Share, by End-user (2021)

Figure 06: Global Vagus Nerve Stimulator Market Value Share, by End-user (2021)

Figure 07: Global Vagus Nerve Stimulator Market Analysis and Forecast, by Product Type, 2021 and 2031

Figure 08: Global Vagus Nerve Stimulator Market Attractiveness Analysis, by Product Type, 2022–2031

Figure 09: Global Vagus Nerve Stimulator Market (US$ Mn), by Implantable, 2017–2031

Figure 10: Global Vagus Nerve Stimulator Market (US$ Mn), by Non-invasive (tVNS), 2017-2031

Figure 11: Global Vagus Nerve Stimulator Market Analysis and Forecast, by Biomaterial, 2021 and 2031

Figure 12: Global Vagus Nerve Stimulator Market Attractiveness Analysis, by Biomaterial, 2022–2031

Figure 13: Global Vagus Nerve Stimulator Market (US$ Mn), by Ceramics, 2017–2031

Figure 14: Global Vagus Nerve Stimulator Market (US$ Mn), by Metallic, 2017-2031

Figure 15: Global Vagus Nerve Stimulator Market (US$ Mn), by Polymeric, 2017-2031

Figure 16: Global Vagus Nerve Stimulator Market Analysis and Forecast, by Application, 2021 and 2031

Figure 17: Global Vagus Nerve Stimulator Market Attractiveness Analysis, by Application, 2022–2031

Figure 18: Global Vagus Nerve Stimulator Market (US$ Mn), by Pain Management, 2017–2031

Figure 19: Global Vagus Nerve Stimulator Market (US$ Mn), by Epileptic Seizures, 2017-2031

Figure 20: Global Vagus Nerve Stimulator Market (US$ Mn), by Depression and Anxiety, 2017–2031

Figure 21: Global Vagus Nerve Stimulator Market (US$ Mn), by Others, 2017-2031

Figure 22: Global Vagus Nerve Stimulator Market Analysis and Forecast, by End-user, 2021 and 2031

Figure 23: Global Vagus Nerve Stimulator Market Attractiveness Analysis, by End-user, 2022–2031

Figure 24: Global Vagus Nerve Stimulator Market (US$ Mn), by Hospitals, 2017–2031

Figure 25: Global Vagus Nerve Stimulator Market (US$ Mn), by Ambulatory Surgical Centers (ASCs), 2017-2031

Figure 26: Global Vagus Nerve Stimulator Market (US$ Mn), by Others, 2017-2031

Figure 27: Global Vagus Nerve Stimulator Market Value Share Analysis, by Region, 2021 and 2031

Figure 28: Global Vagus Nerve Stimulator Market Attractiveness, by Region, 2022-2031

Figure 29: North America Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, 2017–2031

Figure 30: North America Vagus Nerve Stimulator Market Analysis and Forecast, by Product Type, 2021 and 2031

Figure 31: North America Vagus Nerve Stimulator Market Attractiveness Analysis, by Product Type, 2022–2031

Figure 32: North America Vagus Nerve Stimulator Market Analysis and Forecast, by Biomaterial, 2021 and 2031

Figure 33: North America Vagus Nerve Stimulator Market Attractiveness Analysis, by Biomaterial, 2022–2031

Figure 34: North America Vagus Nerve Stimulator Market Analysis and Forecast, by Application, 2021 and 2031

Figure 35: North America Vagus Nerve Stimulator Market Attractiveness Analysis, by Application, 2022–2031

Figure 36: North America Vagus Nerve Stimulator Market Analysis and Forecast, by End-user, 2021 and 2031

Figure 37: North America Vagus Nerve Stimulator Market Attractiveness Analysis, by End-user, 2022–2031

Figure 38: North America Vagus Nerve Stimulator Market Analysis and Forecast, by Country, 2021 and 2031

Figure 39: North America Vagus Nerve Stimulator Market Attractiveness Analysis, by Country, 2022–2031

Figure 40: Europe Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, 2017–2031

Figure 41: Europe Vagus Nerve Stimulator Market Analysis and Forecast, by Product Type, 2021 and 2031

Figure 42: Europe Vagus Nerve Stimulator Market Attractiveness Analysis, by Product Type, 2022–2031

Figure 43: Europe Vagus Nerve Stimulator Market Analysis and Forecast, by Biomaterial, 2021 and 2031

Figure 44: Europe Vagus Nerve Stimulator Market Attractiveness Analysis, by Biomaterial, 2022–2031

Figure 45: Europe Vagus Nerve Stimulator Market Analysis and Forecast, by Application, 2021 and 2031

Figure 46: Europe Vagus Nerve Stimulator Market Attractiveness Analysis, by Application, 2022–2031

Figure 47: Europe Vagus Nerve Stimulator Market Analysis and Forecast, by End-user, 2021 and 2031

Figure 48: Europe Vagus Nerve Stimulator Market Attractiveness Analysis, by End-user, 2022–2031

Figure 49: Europe Vagus Nerve Stimulator Market Analysis and Forecast, Country/Sub-region, 2021 and 2031

Figure 50: Europe Vagus Nerve Stimulator Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 51: Asia Pacific Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, 2017–2031

Figure 52: Asia Pacific Vagus Nerve Stimulator Market Analysis and Forecast, by Product Type, 2021 and 2031

Figure 53: Asia Pacific Vagus Nerve Stimulator Market Attractiveness Analysis, by Product Type, 2022–2031

Figure 54: Asia Pacific Vagus Nerve Stimulator Market Analysis and Forecast, by Biomaterial, 2021 and 2031

Figure 55: Asia Pacific Vagus Nerve Stimulator Market Attractiveness Analysis, by Biomaterial, 2022–2031

Figure 56: Asia Pacific Vagus Nerve Stimulator Market Analysis and Forecast, by Application, 2021 and 2031

Figure 57: Asia Pacific Vagus Nerve Stimulator Market Attractiveness Analysis, by Application, 2022–2031

Figure 58: Asia Pacific Vagus Nerve Stimulator Market Analysis and Forecast, by End-user, 2021 and 2031

Figure 59: Asia Pacific Vagus Nerve Stimulator Market Attractiveness Analysis, by End-user, 2022–2031

Figure 60: Asia Pacific Vagus Nerve Stimulator Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031

Figure 61: Asia Pacific Vagus Nerve Stimulator Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 62: Latin America Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, 2017–2031

Figure 63: Latin America Vagus Nerve Stimulator Market Analysis and Forecast, by Product Type, 2021 and 2031

Figure 64; Latin America Vagus Nerve Stimulator Market Attractiveness Analysis, by Product Type, 2022–2031

Figure 65: Latin America Vagus Nerve Stimulator Market Analysis and Forecast, by Biomaterial, 2021 and 2031

Figure 66: Latin America Vagus Nerve Stimulator Market Attractiveness Analysis, by Biomaterial, 2022–2031

Figure 67: Latin America Vagus Nerve Stimulator Market Analysis and Forecast, by Application, 2021 and 2031

Figure 68: Latin America Vagus Nerve Stimulator Market Attractiveness Analysis, by Application, 2022–2031

Figure 69: Latin America Vagus Nerve Stimulator Market Analysis and Forecast, by End-user, 2021 and 2031

Figure 70: Latin America Vagus Nerve Stimulator Market Attractiveness Analysis, by End-user, 2022–2031

Figure 71: Latin America Vagus Nerve Stimulator Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031

Figure 72: Latin America Vagus Nerve Stimulator Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 73: Middle East & Africa Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, 2017–2031

Figure 74: Middle East & Africa Vagus Nerve Stimulator Market Analysis and Forecast, by Product Type, 2021 and 2031

Figure 75: Middle East & Africa Vagus Nerve Stimulator Market Attractiveness Analysis, by Product Type, 2022–2031

Figure 76: Middle East & Africa Vagus Nerve Stimulator Market Analysis and Forecast, by Biomaterial, 2021 and 2031

Figure 77: Middle East & Africa Vagus Nerve Stimulator Market Attractiveness Analysis, by Biomaterial, 2022–2031

Figure 78: Middle East & Africa Vagus Nerve Stimulator Market Analysis and Forecast, by Application, 2021 and 2031

Figure 79: Middle East & Africa Vagus Nerve Stimulator Market Attractiveness Analysis, by Application, 2022–2031

Figure 80; Middle East & Africa Vagus Nerve Stimulator Market Analysis and Forecast, by End-user, 2021 and 2031

Figure 81: Middle East & Africa Vagus Nerve Stimulator Market Attractiveness Analysis, by End-user, 2022–2031

Figure 82: Middle East & Africa Vagus Nerve Stimulator Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031

Figure 83: Middle East & Africa Vagus Nerve Stimulator Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Copyright © Transparency Market Research, Inc. All Rights reserved